Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.

Medtronic plc.

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Medtronic (MDT), Pharvaris (PHVS) and Amgen (AMGN) w...

Analysts Are Bullish on Top Healthcare Stocks: Medtronic (MDT), Pharvaris (PHVS)

Electrolux AB ( ($SE:ELUX.B) ) just unveiled an announcement. Electrolux Group will cease manufacturing operations at its factory in Santiago, Chil...

Electrolux to Close Chile Factory, Booking SEK 0.5 Billion Restructuring Charge

Electrolux AB ( ($SE:ELUX.B) ) has issued an announcement. Electrolux AB’s Annual General Meeting in Stockholm approved the 2025 financial statemen...

Electrolux AGM Backs Board, Halts 2025 Dividend and Approves New Long-Term Share Plan

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Amylyx Pharmaceuticals Inc (AMLX), AbSci (ABSI) and ...

Analysts Offer Insights on Healthcare Companies: Amylyx Pharmaceuticals Inc (AMLX), AbSci (ABSI) and Medtronic (MDT)

The latest announcement is out from Medtronic ( ($MDT) ). On March 18, 2026, MiniMed announced early U.S. FDA clearance of the MiniMed Flex, a disc...

Medtronic Cuts Fiscal 2026 EPS Outlook After MiniMed Charges

IHI, IHE, ARKG: Specialty Healthcare ETFs Offer Diversification and Growth to Investors

Healthcare is diverse sector of the economy. 


Current Quarter	$1.62	Next Quarter	$1.38
Current Year	$5.6	Next Year	$6.09
QoQ Growth	-14.8%	YoY Growth	+8.8%
3Y EPS CAGR	-1.1%	Target Price	$110.13
Consensus	Buy	Upside	+24.2%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	MDT	$88.65	0.00%	12.47M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	MDT	$88.65	0%	12.47M
3
4
5
6

MDT

MDT

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Medtronic plc. Data in Excel

Get Medtronic plc. Data in Excel